Cormorant Asset Management, LP

Position in DRUG — Bright Minds Biosciences Inc.

CIK 1583977 BOSTON, MA

Position in DRUG

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$77,299,383

-$5,370,808 QoQ

Shares Held

1,059,331

0.0% QoQ

Ownership

10.8%

of shares outstanding

% of Portfolio

3.90%

of 13F equity value

Holder Rank

of 93 holders

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cormorant Asset Management, LP holds $1,914,987,088 across 43 Biotechnology names. DRUG ranks #11 (4.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	885,500	$285,299,245
2	BBOT	BridgeBio Oncology Therapeutics, Inc.	17,878,594	$160,013,416
3	EYPT	EyePoint, Inc.	8,265,000	$106,535,850
4	EWTX	Edgewise Therapeutics, Inc.	3,260,000	$102,690,000
5	ERAS	Erasca, Inc.	5,800,000	$93,844,000
6	RAPP	Rapport Therapeutics, Inc.	2,957,521	$92,540,832
7	ALMS	Alumis Inc.	3,949,241	$87,001,779
8	ABVX	Abivax S.A.	760,000	$84,626,000

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-04-28	$84,540,500	950,000	-10.3%	Shares	Sole	2026-04-30
2026-03-31	$77,299,383	1,059,331	0.0%	Shares	Defined	2026-05-15
2026-01-31	$82,362,985	1,059,331	0.0%	Shares	Sole	2026-02-06
2025-12-31	$82,670,191	1,059,331	0.0%	Shares	Defined	2026-02-17
2025-09-30	$64,259,018	1,059,331	0.0%	Shares	Defined	2025-11-14
2025-06-30	$27,659,132	1,059,331	0.0%	Shares	Defined	2025-08-14
2025-03-31	$38,210,069	1,059,331	0.0%	Shares	Defined	2025-05-15
2024-12-31	$38,157,102	1,059,331	—	Shares	Defined	2025-02-14
No filing history on record for this holder in this stock.